In the latest trading session,, 0.5 million Enzo Biochem, Inc (NYSE:ENZ) shares changed hands as the company’s beta touched 1.09. With the company’s most recent per share price at $0.30 changed hands at -$0.02 or -7.60% at last look, the market valuation stands at $15.74M. ENZ’s current price is a discount, trading about -286.67% off its 52-week high of $1.16. The share price had its 52-week low at $0.25, which suggests the last value was 16.67% up since then. When we look at Enzo Biochem, Inc’s average trading volume, we note the 10-day average is 0.41 million shares, with the 3-month average coming to 181.51K.
Enzo Biochem, Inc (NYSE:ENZ) trade information
Instantly ENZ was in red as seen in intraday trades today. With action -9.68%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -57.96%, with the 5-day performance at -9.68% in the red. However, in the 30-day time frame, Enzo Biochem, Inc (NYSE:ENZ) is -33.12% down. Looking at the short shares, we see there were 0.31 million shares sold at short interest cover period of 2.75 days.
Enzo Biochem, Inc (NYSE:ENZ)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 21.68% of Enzo Biochem, Inc shares while 34.80% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 44.43%. There are 34.80% institutions holding the Enzo Biochem, Inc stock share, with HARBERT FUND ADVISORS, INC. the top institutional holder. As of 2024-06-30, the company held 9.9072% of the shares, roughly 5.18 million ENZ shares worth $5.64 million.
RENAISSANCE TECHNOLOGIES LLC holds the second largest percentage of outstanding shares, with 4.7844% or 2.5 million shares worth $2.72 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 1.19 shares estimated at $0.36 million under it, the former controlled 2.27% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 1.18% of the shares, roughly 618.88 shares worth around $0.19 million.
